Skip to main content
. Author manuscript; available in PMC: 2021 Jan 1.
Published in final edited form as: Res Nurs Health. 2019 Oct 10;43(1):48–55. doi: 10.1002/nur.21985

Table 3.

Association Between Individual Symptom Severity and Presence of Fatigue among Emerging Adults with Inflammatory Bowel Disease

Unadjusted Adjusteda

OR P OR P
Abdominal cramps 1.49
[1.13, 1.95]
0.01 1.48
[1.09, 2.0]
0.01
Abdominal pain 1.5
[1.16, 2.14]
0.01 1.53
[1.11, 2.11]
0.01
Diarrhea 1.44
[1.09, 1.89]
0.01 1.41
[1.05, 1.91]
0.02
Passing gas 1.32
[1.05, 1.65]
0.02 1.30
[1.02, 1.68]
0.03
Abdominal Tenderness 1.49
[1.08, 2.05]
0.02 1.43
[1.01, 2.02]
0.04
Bloating 1.39
[1.04, 1.86]
0.03 1.38
[1.0, 1.92]
0.05
Reduced appetite 1.51
[0.97, 2.33]
0.07 1.64
[0.99, 2.72]
0.06
Blood in stool 1.28
[0.87, 1.87]
0.21 1.27
[0.83, 1.94]
0.28
Nausea or vomiting 1.18
[0.92, 1.51]
0.20 1.20
[0.90, 1.59]
0.21
Weight loss 1.09
[0.52, 2.27]
0.83 1.21
[0.56, 2.62]
0.63
Constipation 1.02
[0.8, 1.3]
0.86 0.96
[0.73, 1.26]
0.77
Increased appetite 1.01
[0.71, 1.43]
0.95 0.98
[0.67, 1.44]
0.93

OR = Odds Ratio

a

Adjusted for age, emerging adulthood IDEA-8 score, the interaction between age and emerging adulthood IDEA-8 score, gender, disease type, and current steroid use.

Note: The interaction between age and emerging adulthood IDEA-8 score was included since the effect of age may differ based on developmental stage. All participants reporting weight gain (n = 3) and fever (n = 3) also reported the presence of fatigue.